Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 3
1994 4
1995 8
1996 3
1997 3
1998 6
1999 14
2000 12
2001 17
2002 10
2003 15
2004 14
2005 11
2006 27
2007 28
2008 22
2009 21
2010 19
2011 29
2012 38
2013 31
2014 31
2015 42
2016 24
2017 18
2018 27
2019 15
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

440 results
Results by year
Filters applied: . Clear all
Page 1
Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials.
O'Neil PM, Aroda VR, Astrup A, Kushner R, Lau DCW, Wadden TA, Brett J, Cancino AP, Wilding JPH; Satiety and Clinical Adiposity - Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups. O'Neil PM, et al. Diabetes Obes Metab. 2017 Nov;19(11):1529-1536. doi: 10.1111/dom.12963. Epub 2017 Jul 21. Diabetes Obes Metab. 2017. PMID: 28386912 Free PMC article.
Randomized phase II clinical trials.
Jung SH, Sargent DJ. Jung SH, et al. J Biopharm Stat. 2014;24(4):802-16. doi: 10.1080/10543406.2014.901343. J Biopharm Stat. 2014. PMID: 24697589 Free PMC article.
440 results
Jump to page
Feedback